# Lepu Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lepu-biotech

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Total disclosed funding: $316M
- Latest round: Series B (Aug 6, 2020)
- Investors on record: 12

## About

Established in 2018 and based in Shanghai, China, Lepu Biotech operates as a biopharmaceutical company focusing on the field of tumor treatment.

The company has developed a pipeline of multiple oncology products, including eight clinical-stage candidates, three preclinical candidates and three clinical-stage candidates. Its pipeline covers the main nodes of the tumor immune cycle, such as immune desert tumors and inflammatory tumors.

## Funding rounds

- Series B, Aug 6, 2020, $185M — Haitong Innovation Capital Management, Riverhead Capital, SDIC Unity Capital, Sunshine Life Insurance, Guoxin Central Enterprise Investment Fund Management(Guangzhou), Ping An Capital, Minhe Capital
- Series A, Jul 1, 2019, $131M — Shiyu Capital, Kaiyuan Guochuang Asset Management, Sumin Investment, Lepu Medical Technology Beijing, Lecheng Medical Care

## Investors

- Shiyu Capital (https://capitalatlas.ai/funds/shiyu-capital) — Series A
- Kaiyuan Guochuang Asset Management — Series A
- Sumin Investment (https://capitalatlas.ai/funds/sumin-investment) — Series A
- Lepu Medical Technology Beijing — Series A
- Lecheng Medical Care — Series A
- Haitong Innovation Capital Management (https://capitalatlas.ai/funds/haitong-innovation-capital-management) — Series B
- Riverhead Capital (https://capitalatlas.ai/funds/riverhead-capital) — Series B
- SDIC Unity Capital (https://capitalatlas.ai/funds/sdic-unity-capital) — Series B
- Sunshine Life Insurance — Series B
- Guoxin Central Enterprise Investment Fund Management(Guangzhou) — Series B
- Ping An Capital — Series B
- Minhe Capital (https://capitalatlas.ai/funds/minhe-capital) — Series B